In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
In this Q&A, Jordana B. Cohen, MD, MSCE, assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine, and a nephrologist and research scientist at the...
In this Q&A, Ping Liu, PhD, and Pietro Ravani, MD, PhD, answer our questions about the diagnosis and management of chronic kidney disease (CKD) and discuss how the current definition of CKD does not...
In a recent study, researchers examined how chronic kidney disease care differed among patients of different races and ethnicities. Lead study author Chi Chu, MD, MAS, answered our questions on his team’s...
The researchers investigated 4-week prophylaxis combination therapy before and after kidney transplantation between donors and recipients with HCV. Lead author Christine M. Durand, MD, answered our...
Emerging data suggest that acute kidney injury may have long-term cerebrovascular consequences, including heightened dementia risk. Consultant360 spoke with Dr Jessica Kendrick from the University of...
Diabetes, cardiovascular disease, and kidney disease are leading causes of death in the United States, but what else do they have in common? In this Q&A, Dr Thomas Zelniker explains how these 3 diseases...
